In other countries
The same active substances on other registers, the same brand first.
- RevlimidCanada · 20 MG · Capsule · Bristol-Myers Squibb CanadaSame brand
- RevlimidCanada · 10 MG · Capsule · Bristol-Myers Squibb CanadaSame brand
- RevlimidCanada · 15 MG · Capsule · Bristol-Myers Squibb CanadaSame brand
- Revlimid 10 MG Capsulas DurasSpain · 10 mg · cápsula dura · Bristol-Myers Squibb Pharma EeigSame brand
- Revlimid 15 MG Capsulas DurasSpain · 15 mg · cápsula dura · Bristol-Myers Squibb Pharma EeigSame brand
- Revlimid 20 MG Capsulas DurasSpain · 20 mg · cápsula dura · Bristol-Myers Squibb Pharma EeigSame brand
- RevlimidEuropean Union · Bristol-Myers Squibb Pharma EEIGSame brand
- RevlimidCroatiaSame brand
- RevlimidItaly · Capsula rigida · Bristol-Myers Squibb Pharma EeigSame brand
- Revlimid 10 mg harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame brand
- Revlimid 15 mg harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame brand
- Revlimid 2,5 mg harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame brand
- Revlimid®Serbia · 25mg · kapsula, tvrda · Amicus SRB D.O.O.Same brand
- Revlimid®Serbia · 10mg · kapsula, tvrda · Amicus SRB D.O.O.Same brand
- REVLIMID 10 mg capsuleSaudi Arabia · Celgene InternationalSame brand
- REVLIMID 15 mg capsuleSaudi Arabia · Celgene InternationalSame brand
- REVLIMID 25 mg capsuleSaudi Arabia · Celgene InternationalSame brand
- Revlimid Capsules 10mgSingapore · 10.0 mg · capsule · Bristol-Myers Squibb (Singapore) Pte. LTD.Same brand
- Revlimid Capsules 15 mgSingapore · 15.0 mg · capsule · Bristol-Myers Squibb (Singapore) Pte. LTD.Same brand
- Revlimid Capsules 25 mgSingapore · 25.0 mg · capsule · Bristol-Myers Squibb (Singapore) Pte. LTD.Same brand
- RevlimidUnited States · 10MG, 15MG, 2.5MG … · capsule · Bristol Myers SquibbSame brand
- Lenalidomide AccordEuropean Union · Accord Healthcare S.L.U.Same form
- Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka)European Union · Krka, d.d., Novo mestoSame form
- Lenalidomid AccordCroatiaSame form
- Lenalidomid Krka d.d. Novo mestoCroatiaSame form
- Lenli Capsules 10mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same form
- Lenli Capsules 15mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same form
- Lenli Capsules 2.5mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same form
- LenalinovaArgentina · 15 MG, 5 MG · cápsula dura · Celnova Argentina S.A.Same substance
- KlederItaly · Capsula rigida · Eg S.P.A.Same substance
- Lenalidomide AccordItaly · Capsula rigida · Accord Healthcare, S.L.U.Same substance
- Lenalidomide ViatrisNew Zealand · Cap 15 mgSame substance
- Lenalidomide ViatrisNew Zealand · Cap 10 mgSame substance
- Lenalidomide ViatrisNew Zealand · Cap 25 mgSame substance
- LENALIDOMIDA ALVOGEN 10 mgRomania · 10mg · caps. · Alvogen Malta Operations (Row) LTD.Same substance
- LENALIDOMIDA ALVOGEN 15 mgRomania · 15mg · caps. · Alvogen Malta Operations (Row) LTD.Same substance
- LENALIDOMIDA ALVOGEN 25 mgRomania · 25mg · caps. · Alvogen Malta Operations (Row) LTD.Same substance
- EUlenSerbia · 10mg · kapsula, tvrda · Eupharm PHC DOOSame substance
- LenalidomideUnited States · 10MG, 15MG, 2.5MG … · capsule · CiplaSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Lenalidomide
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 29 Nov 2021
- Registration
- 101800410
- Marketing authorisation holder
- Bristol-Myers Squibb Farmacêutica Ltda
- ATC code
- L04AX
- Procedure
- Registered